Darnytsia — on the Same Wavelength as the World’s Pharmaceutical Giants: ISO Surveillance Audit Successfully Completed

Darnytsia Pharmaceutical Company has successfully completed a surveillance audit according to international standards:

•    ISO 45001:2018 — Occupational Health and Safety Management Systems (hereinafter — ISO 45001);
•    and ISO 14001:2015 — Environmental Management Systems (hereinafter — ISO 14001).

The audit was completed without any critical remarks, which confirms our commitment to high standards of safety and environmental protection.

To recap, ISO 45001 is a standard that helps create safe working conditions and reduce risks for employees. At the same time, ISO 14001 sets requirements for environmental management and helps minimize environmental impact.

Darnytsia, like leading global pharmaceutical companies, adheres to these standards because they guarantee not only employee safety and care for the environment, but also directly influence the quality of medicinal products.

A safe and clean production environment reduces the risk of errors, contamination, and substandard products. Compliance with these standards means that every stage of production is controlled, and the final product meets the highest requirements for quality and safety for patients.

”Darnytsia demonstrates a commitment to continuous improvement, transparency, and care for people and the environment. I am truly proud of our team. For us, these standards are not just a requirement, but a part of our culture. Every day, we take care of safety, comfort, ecology, and, of course, the impeccable quality of our medicines. I thank everyone for their contribution to our shared success,” says Ihor Perepelytsia, Technical Director of Darnytsia.